Objective: Investigating the causal relationship between non-alcoholic fatty liver disease (NAFLD) and inflammatory proteins and identifying and quantifying the role of serum metabolites as a potential mediator.
Methods: Using summary-level data from a genome-wide association study (GWAS), a two-sample Mendelian randomization (MR) analysis of genetically predicted Nonalcoholic Fatty Liver Disease and inflammatory proteins (14,824 participants of primarily European descent) was performed. Then we did a MR analysis of inflammatory factors with non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma.
Results: The IVW method analysis showed that CCL20 (P-value=0.023, OR=0.783, 95% CI=0.644-0.968), IL-1α(P-value=0.039, OR=0.790, 95% CI=0.632-0.988) were protective factors for NAFLD, while TNFRSF9 (P-value<0.001, OR=1.353, 95% CI=1.148-1.594) was a risk factor. IL-10Rα(P-value=0.004, OR=3.274, 95% CI=1.463-7.027), NT-3 (P-value=0.040, OR=2.413, 95% CI=1.040-5.601), SLAM (P-value=0.009, OR=2.183, 95% CI=1.216-3.918) were identified as risk factors for NASH. LIFR (P-value<0.001, OR=0.704, 95% CI=0.595-0.832) was identified as a protective factor for cirrhosis. IL-1α (P-value=0.002, OR=2.274, 95% CI=1.369-3.778) was identified as a risk factor for HCC.
Conclusion:In conclusion, our study identified a causal relationship between inflammatory proteins and Nonalcoholic Fatty Liver Disease.